BDBM531337 3-Methyl-2-(6-(((1R,2R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-2-yl)amino)pyridazin-3-yl)-5-(trifluoromethyl)phenol::US11208399, Example 85b

SMILES Cc1cc(C(F)(F)F)cc(O)c1-c1ccc(NC2CCC3CCC2N3C)nn1

InChI Key InChIKey=HEJBOEPMWOSUGD-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 531337   

TargetInterleukin-1 beta(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 531337BDBM531337(US11208399, Example 85b | 3-Methyl-2-(6-(((1R,2R,5...)
Affinity DataIC50: 1.30nMAssay Description:Monocytic THP-1 cells (ATCC: TIB-202) were maintained according to providers' instructions in RPMI media (RPMI/Hepes+10% fetal bovine serum+Sodiu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
US Patent

TargetTumor necrosis factor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 531337BDBM531337(US11208399, Example 85b | 3-Methyl-2-(6-(((1R,2R,5...)
Affinity DataIC50: 1.00E+5nMAssay Description:Monocytic THP-1 cells were maintained according to providers' instructions in RPMI media as described above. Undifferentiated cells were plated a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
US Patent